Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about DMT
Recent news which mentions DMT
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Tickers
DMT
ENVB
NEWS
Tags
Psychedelics mental health
premium
Benzinga
From
Benzinga
Divine Supply: How A California Church Became A Psychedelics And Weed Sanctuary Challenging Federal Prohibition
May 06, 2024
Tickers
DMT
Tags
California cannabis
psilocybin mushrooms
Church of Ambrosia
From
Benzinga
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
Tickers
CMND
CMND
DMT
NEWS
Tags
CMND
Psychedelics
Oz Adler
From
Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
Tickers
DEA
DMT
MDMA
NEWS
Tags
marijuana research
DEA Cannabis
Psychedelics
From
Benzinga
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
December 13, 2023
Tickers
DMT
MDMA
Tags
General
Psychedelic Therapy
Markets
From
Benzinga
Psychedelics In Mexico: Are They Legal? Well, Yes And No
December 10, 2023
Tickers
DMT
Tags
Mexico
Psilocybin
Psychedelics
From
Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
Tickers
CYBN
DMT
DMTTF
Tags
M&A
CYBN
News
From
Benzinga
The Fear Of Death Dissolved: How Psychedelic Trips And Near-Death Moments Change Our Outlook On Life's End
August 17, 2023
Tickers
DMT
Tags
Cannabis
Market News
Benzinga
From
Benzinga
How DMT Affects The Brain's Advanced Functions, Scientists Reveal The Truth
April 29, 2023
Tickers
DMT
Tags
Study
Psychedelics
General
From
Benzinga
Study Sheds Light On How A Brain On Ayahuasca's Psychedelic Component Looks
March 24, 2023
Tickers
DMT
Tags
Benzinga
Psychedelic/Assisted Therapies
Global
From
Benzinga
DMT VS. Psilocybin: Are We All Experiencing The Same Trip?
February 10, 2023
Tickers
DMT
Tags
Benzinga
contributors
Cannabis
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
Psychedelics
Market News
Cybin
From
Benzinga
Top 3 Psychedelic Storylines To Watch In 2023
January 29, 2023
Tickers
ATAI
CMPS
DMT
MDMA
Tags
Penny Stocks
contributors
Benzinga
From
Benzinga
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
January 26, 2023
Tickers
DMT
FLHLF
Tags
Ayahuasca
Management
News
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
Benzinga
Psychedelic/Assisted Therapies
Penny Stocks
From
Benzinga
Ayahuasca's Benefits Outweigh Risks, A New Australian Study Finds
November 28, 2022
Tickers
DMT
Tags
DMT
Market News
Markets
From
Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
Tickers
DMT
DMTTF
Tags
Short/Acting Psychedelics
News
Legal
From
Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
Tickers
AGNPF
DMT
Tags
Medical Research Ethics Committee
DMT
Markets
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
News
Magic Mushrooms
Retail Sales
From
Benzinga
Science Feature: Next-Generation Psychedelics
July 31, 2022
Tickers
DMT
Tags
contributors
Benzinga
DMT
From
Benzinga
Encountering DMT Entities: Are They Real?
June 23, 2022
Tickers
DMT
Tags
Benzinga
contributors
Cannabis
From
Benzinga
A Deeper Look At DMT Trials & Studies
June 14, 2022
Tickers
DMT
Tags
Cannabis
Markets
Market News
From
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
Tickers
CYBN
DMT
PCC
Tags
Markets
Exclusives
DMT
From
Benzinga
Extending the Experience: Interview With DMT Pioneer Rick Strassman
April 16, 2022
Tickers
DMT
Tags
Psychedelics
Benzinga
Rick Strassman
From
Benzinga
Top 5 Most Influential Psychedelic Studies
March 29, 2022
Tickers
DMT
MDMA
Tags
depression
Market News
Cannabis
From
Benzinga
Forget Shrooms, Is Toad Venom The New Hallucinogenic Drug For The Rich And Famous?
March 06, 2022
Tickers
DMT
Tags
toad venom
Bufo
psychedelics
From
Benzinga
DMT Vape Pen Patent Illustrates A Big Problem In The Psychedelics Industry
February 14, 2022
Tickers
DMT
Tags
Benzinga
contributors
Patents
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
psychedelics
5/MeO/DMT
Kaivalya Kollectiv
From
Benzinga
Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient
February 03, 2022
Tickers
DMT
ENTBF
Tags
Benzinga
Penny Stocks
Cannabis
From
Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
Tickers
DMT
MDMA
Tags
Doc Gumshoe
AdvisorShares Psychedelics ETF (PSIL)
Ibogaine
From
Stock Gumshoe
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.